Vascarta, Inc.


Vascarta Inc. is a pharmaceutical company that has developed a patented topical/transdermal delivery platform aimed at improving the bioavailability of drugs, particularly curcumin, a compound known for its anti-inflammatory and antioxidant properties. The company focuses on addressing unmet medical needs through innovative formulations that enhance therapeutic efficacy and patient outcomes.

Industries

health-care
medical
pharmaceutical

Nr. of Employees

small (1-50)

Vascarta, Inc.

Summit, New Jersey, United States, North America


Products

Topical/transdermal curcumin gel formulation (8.5% curcumin)

A topical/transdermal gel formulation containing curcumin formulated for enhanced solubility and deep skin penetration; supplied in a metered applicator for prescription use.


Services

Licensing and partnering for transdermal formulation development

Collaborative licensing, acquisition, or research partnerships to apply the transdermal delivery platform to partner molecules, alone or combined with botanicals, and to conduct preclinical or clinical studies.

Provision of formulation for academic research

Supply of transdermal formulation variants to academic collaborators for preclinical studies.

Prescription fulfillment and patient support via compounding pharmacy

Dispensing of the topical/transdermal curcumin formulation through a designated licensed compounding pharmacy with state-specific shipping and patient contact information.

Expertise Areas

  • Transdermal drug delivery
  • Formulation chemistry for poorly water-soluble compounds
  • Preclinical pharmacology and animal models
  • Clinical safety study conduct (GCP)
  • Show More (4)

Key Technologies

  • Topical/transdermal delivery
  • Solubility enhancement for hydrophobic compounds
  • Metered topical applicator dosing
  • Custom extraction and HPLC for curcuminoids
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.